AM-211 sodium
This active molecular is a potent Prostaglandin D2 receptor antagonists and has been in phase I clinical trials for both COPD (chronic obstructive pulmonary disease) and asthma, but no recent results has been published.
| Supplier | BOC Sciences |
|---|---|
| Product # | 1263077-74-2 |
| Pricing | Inquire |
| Cas | 1263077-74-2 |
| Molecular Weight | 522.50 |
| Molecular Formula | C27H26F3N2O4Na |
| Canonical SMILES | CCN(Cc1cc(ccc1c2cc(ccc2OC)CC(=O)[O-])C(F)(F)F)C(=O)NCc3ccccc3.[Na+] |